$19.30
Today
as of Jul 22, 16:45 ET
Last 30 days
Recent Press Releases & News
AMPH: Raising target price to $19.00
AMPH: Lowering target price to $18.00
Amphastar Unit Receives US FDA Warning Letter on Violations at California Facility
Overview
52-week range
$17
$31
18% of range
Avg surprise (last 3)
-11.9%
Avg reaction (last 2)
+1.4%
100% positive
Latest IV / EM
49%
EM ±11.1% · $20 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $0.26 | $0.62 | -58.1% | -57.4% | +0.5% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.37 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $0.75 | $0.64 | +17.2% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $0.61 | $0.58 | +5.2% | — | +2.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.78 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.73 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.81 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.91 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.49 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | $0.58 | $0.75 | -22.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $171M | — | $192M | $174M | $171M | — | $191M | $182M |
| Cost of revenue | $101M | — | $93M | $88M | $85M | — | $89M | $87M |
| Gross profit | $70M | — | $99M | $86M | $85M | — | $102M | $95M |
| Operating income | $14M | — | $25M | $42M | $37M | — | $57M | $55M |
| Net income | $6M | — | $17M | $31M | $25M | — | $40M | $38M |
| EPS (diluted) | $0.14 | — | $0.37 | $0.64 | $0.51 | — | $0.78 | $0.73 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $171M | $170M | $216M | $188M | $183M | $152M | $192M | $190M |
| Inventory | $170M | $177M | $186M | $192M | $185M | $154M | $130M | $122M |
| Total current assets | $634M | $636M | $639M | $581M | $588M | $534M | $546M | $483M |
| Total assets | $1.65B | $1.63B | $1.67B | $1.62B | $1.63B | $1.58B | $1.55B | $1.49B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $875M | $840M | $889M | $858M | $875M | $845M | $818M | $778M |
| Total equity | — | — | — | — | — | — | — | — |